CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹306 Cr | ₹331 Cr | ₹268 Cr | ₹208 Cr | ₹143 Cr |
What is the latest Total Current Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹306 Cr |
| Mar2024 | ₹331 Cr |
| Mar2023 | ₹268 Cr |
| Mar2022 | ₹208 Cr |
| Mar2021 | ₹143 Cr |
How is Total Current Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹306 Cr | -7.51 | |
| Mar2024 | ₹331 Cr | 23.45 | |
| Mar2023 | ₹268 Cr | 29.04 | |
| Mar2022 | ₹208 Cr | 45.38 | |
| Mar2021 | ₹143 Cr | - | |
Compare Total Current Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹19,206.7 Cr | -0.8% | 19.8% | 28.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -0.8% |
19.8% |
28.4% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses